{"text_format":"2","workbook":"xls","n_sheets":1,"sheets":["report2"],"not_rendered":{"charts":0,"images":0,"macros":0,"external_links":1,"defined_names":1,"comments":0,"pivot_tables":0},"unopened":[],"bounds":{"document_bytes":16777216,"sheet_cells":100000,"run_cost":"one","rows_first":2000,"rows_last":500,"rows_between":2000,"halvings":0,"cell_chars":16384,"cell_head_chars":4096},"cells_cut":0,"cells_raw":0,"read":"whole","date_system":"1900","formulas":"cached_only"}

{"sheet":"report2","index":0,"n_rows":16,"n_cols":5,"rows_kept":16,"cut":false,"hidden":false,"merged":[[0,2,0,3],[0,4,0,5],[1,2,1,3],[1,4,1,5],[2,2,2,3],[4,2,4,3],[5,2,5,3],[6,2,6,3],[7,2,7,3],[8,2,8,3],[10,2,10,3],[11,2,11,3],[15,2,15,3]],"flags":["formulas_cached_only"]}
[null,"1.","Record Nr.",null,"UNINA9910780771703321"]
[null,null,"Titolo",null,"Antiepileptic drugs / / editors, René H. Levy [and three others]"]
[null,null,"Pubbl/distr/stampa",null,"Philadelphia : , : Lippincott Williams & Wilkins, , [2002]"]
[{"$nulls":4},"©2002"]
[null,null,"ISBN",null,"1-4698-7726-0"]
[null,null,"Edizione",null,"[Fifth edition.]"]
[null,null,"Descrizione fisica",null,"1 online resource (987 p.)"]
[null,null,"Disciplina",null,"616.8/53061"]
[null,null,"Soggetti",null,"Epilepsy - Chemotherapy"]
[{"$nulls":4},"Anticonvulsants"]
[null,null,"Lingua di pubblicazione",null,"Inglese"]
[null,null,"Formato",null,"Materiale a stampa"]
[null,null,null,"Livello bibliografico","Monografia"]
[null,null,null,"Note generali","Description based upon print version of record."]
[null,null,null,"Nota di bibliografia","Includes bibliographical references and index."]
[null,null,"Nota di contenuto",null,"section I. General principles -- section II. Benzodiazepines -- section III. Carbamazepine -- section IV. Felbamate -- section V. Gabapentin -- section VI. Lamotrigine -- section VII. Levetiracetam -- section VIII. Oxcarbazepine -- section IX. Phenobarbital and other barbiturates -- section X. Phenytoin and other hydantoins -- section XI. Primidone -- section XII. Succinimides -- section XIII. Tiagabine -- section XIV. Topiramate -- section XV. Valproic acid -- section XVI. Vigabatrin -- section XVII. Zonisamide -- section XVIII. Drugs in development."]